The diagnosis of drug-induced liver injury (DILI) is a challenging problem, often confounded
by incomplete clinical information and the difficulty of eliciting exposure to herbal products …

Drug-induced liver injury is a potential complication of nearly every medication that is
prescribed, because the liver is central to the metabolic disposition of virtually all drugs and …

Purpose: To review the literature on the effects of amiodarone on thyroid physiology and
management of amiodarone-induced thyroid disease. Data Sources: English-language …

The prevalence of apparent amiodarone-related hepatic injury in 104 patients followed
prospectively is compared to that reported in the literature. Asymptomatic elevation of serum …

Alcoholic liver disease includes steatosis, alcoholic hepatitis and cirrhosis. Other liver
diseases of genetic origin, but with a curious association with alcohol intake, are …

The Tenth Edition of the Handbook of Clinical Drug Data continues a long tradition of
providing clinically relevant, well-referenced drug information compiled by expert clinicians …

Featuring more than 4100 references, Drug-Induced Liver Disease is an invaluable
reference for gastroenterologists, hepatologists, family physicians, internists, pathologists …

Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease in developed
countries. Its frequency is increasing in the general population mostly due to the widespread …

This analysis of the morphology of suspected amiodarone (AD) liver disease is based on a
study of liver specimens from 17 individuals. Changes similar to alcoholic liver injury were …

The current test systems employed by pharmaceutical industry are poorly predictive for drug-
induced liver injury (DILI). The 'MIP-DILI'project addresses this situation by the development …